Commonwealth Numbered Acts
[Index]
[Table]
[Search]
[Search this Act]
[Notes]
[Noteup]
[Previous]
[Next]
[Download]
[Help]
HEALTH LEGISLATION AMENDMENT ACT 1986 No. 75 of 1986 - SCHEDULE 1
SCHEDULE 1 Section
52
NEW SCHEDULE 1A TO HEALTH INSURANCE ACT 1973
SCHEDULE 1A Section
3
PATHOLOGY SERVICES TABLE
RULES FOR INTERPRETATION OF THE PATHOLOGY SERVICES TABLE
1. Where an item includes the symbol "(SP)", the item shall be taken to relate
to a pathology service to which sub-section 16A (3) applies when rendered by
or on behalf of an approved pathology practitioner who is a recognized
pathologist, other than a pathology service-
(a) rendered pursuant to a request made in the course of the provision of
an out-patient service at a recognized hospital;
(b) rendered pursuant to a request made in respect of a person who was, at
the time when the request was made, a private patient in a recognized
hospital; or
(c) in the rendering of which-
(i) any pathology equipment of a recognized hospital, or a
laboratory included in a prescribed class of laboratories, is
used; or
(ii) any member of the staff of a recognized hospital, or a
laboratory included in a prescribed class of laboratories,
participates.
2. In rule 1, "recognized pathologist" means a medical practitioner who, by
reason of a determination under section 61, is to be recognized for the
purposes of this Act as a specialist in the specialty of pathology.
3. For the purposes of rule 1, each of the following classes of laboratories
is a prescribed class of laboratories:
(a) laboratories operated by the Commonwealth;
(b) laboratories operated by a State or an authority of a State;
(c) laboratories operated by the Northern Territory;
(d) laboratories operated by the Australian Capital Territory Health
Authority;
(e) laboratories operated by an Australian university.
4. Where an item includes the symbol "(OP)", the item shall be taken to relate
to-
(a) a pathology service other than a pathology service-
(i) to which an item that includes the symbol "(SP)" relates; or
(ii) to which sub-section 16A (7) applies; or
(b) a pathology service rendered outside Australia.
5. Each item in Division 9 shall be taken to relate to a pathology service to
which sub-section 16A (7) applies.
6. Where-
(a) a procedure of one of 2 or more kinds of procedure described in an
item (being an item that is expressed to apply in relation to one
procedure) that includes the symbol "(SP)"; or
(b) a procedure of one of 2 or more kinds of procedure described in an
item (being an item that is expressed to apply in relation to one
procedure) that includes the symbol "(OP)", is rendered in respect of
a person by or on behalf of an approved pathology practitioner (in
this rule referred to as the "relevant pathologist") pursuant to a
request, made on a particular day, to the relevant pathologist by-
(c) the practitioner (in this rule referred to as the "treating
practitioner") who determined that the procedure was necessary; or
(d) another approved pathology practitioner who is not the treating
practitioner, and the request is the only such request in respect of a
procedure of that kind, or any other kind described in that item, made
on that day in respect of that person to the relevant pathologist by
the treating practitioner or that other approved pathology
practitioner, that procedure shall be treated as one service
consisting of that procedure.
7. Where-
(a) 2 or more procedures each of which is a procedure of one of 2 or more
kinds of procedure described in an item (being an item that is
expressed, whether directly or indirectly, to apply to that number of
procedures) that includes the symbol "(SP)"; or
(b) 2 or more procedures each of which is a procedure of one of 2 or more
kinds of procedure described in an item (being an item that is
expressed, whether directly or indirectly, to apply to that number of
procedures) that includes the symbol "(OP)", are rendered in respect
of a person by or on behalf of an approved pathology practitioner (in
this rule referred to as the "relevant pathologist") pursuant to a
request, or requests, made on the one day to the relevant pathologist
by-
(c) the practitioner (in this rule referred to as the "treating
practitioner") who determined that the procedures were necessary; or
(d) another approved pathology practitioner who is not the treating
practitioner, those procedures shall, unless the contrary intention
appears, be treated as one service consisting of those procedures.
8. Where-
(a) a procedure of one of 2 or more kinds of procedure described in an
item (being an item that is expressed to apply in relation to one
procedure) that includes the symbol "(OP)", being a procedure
determined on a particular day to be necessary by an approved
pathology practitioner, is rendered in respect of a person by or on
behalf of that approved pathology practitioner; and
(b) the procedure is the only procedure of that kind, or any other kind
described in that item, that was so determined on that day to be
necessary in respect of that person by that approved pathology
practitioner, that procedure shall be treated as one service
consisting of that procedure.
9. Where 2 or more procedures each of which is a procedure of one of 2 or more
kinds of procedure described in an item (being an item that is expressed,
whether directly or indirectly, to apply to that number of procedures) that
includes the symbol "(OP)", being procedures determined on the one day to be
necessary by an approved pathology practitioner are rendered in respect of a
person by or on behalf of that approved pathology practitioner, those
procedures shall, unless the contrary intention appears, be treated as one
service consisting of those procedures.
10. Where-
(a) a procedure of one of the kinds of procedure described in item 2334 is
rendered in respect of a person (in this rule referred to as the
"relevant patient") by or on behalf of a medical practitioner other
than an approved pathology practitioner (in this rule referred to as
the "relevant practitioner") and-
(i) the procedure was determined to be necessary by the relevant
practitioner; or
(ii) the procedure was rendered pursuant to a request made by the
person who determined that the procedure was necessary, being a
medical practitioner other than an approved pathology
practitioner who, at the time when the request was made, was a
member of a group of practitioners, within the meaning of
section 16a, of which the relevant practitioner was then a
member; and
(b) that procedure is the only procedure of that kind, or any other kind
included in that item, that, on the day on which the procedure was
determined to be necessary or on which the request for the procedure
was made, as the case may be, was-
(i) so determined to be necessary in respect of the relevant
patient by the relevant practitioner; or
(ii) so requested in respect of the relevant patient by a medical
practitioner other than an approved pathology practitioner who,
on that day, was a member of a group of practitioners, within
the meaning of section 16A, of which the relevant practitioner
was then a member, that procedure shall be treated as one
service consisting of that procedure.
11. Where-
(a) 2 or more procedures each of which is a procedure of one of the kinds
of procedure described in item 2335 or 2336 are rendered in respect of
a person by or on behalf of a medical practitioner (in this rule
referred to as the "relevant practitioner") other than an approved
pathology practitioner;
(b) each of the procedures was-
(i) determined to be necessary by the relevant practitioner; or
(ii) rendered pursuant to a request made by the person who
determined that the procedure was necessary, being a medical
practitioner other than an approved pathology practitioner who,
at the time when the request was made, was a member of a group
of practitioners, within the meaning of section 16A, of which
the relevant practitioner was then a member; and
(c) each of the procedures was so determined to be necessary, or so
requested, on the one day, those procedures shall be treated as one
service consisting of those procedures.
12. In rules 6 to 11 (inclusive), "procedure" includes an assay, an estimation
and a test.
13. A reference in these rules to a request made to an approved pathology
practitioner includes a reference to a request that is deemed, for the
purposes of section 16A, to have been made to that approved pathology
practitioner.
------------------------------------------------------------------------------
-- Item
No. Pathology Service Fees
-----
N.S.W. Vic. Qld S.A. W.A.
Tas.
------------------------------------------------------------------------------
--
$ $ $ $ $
$
Division 1-Haematology
1006 Blood count consisting of
erythrocyte count,
erythrocyte sedimentation
rate, haematocrit estimation,
haemoglobin estimation,
platelet count, or leucocyte
count-one procedure (SP) ... 5.70 5.70 5.70 5.70 5.70
5.70
1007 Blood count consisting of
erythrocyte count,
erythrocyte sedimentation
rate, haematocrit estimation,
haemoglobin estimation,
platelet count or leucocyte
count-one procedure
(excluding haemoglobin
estimation or erythrocyte
sedimentation rate when not
referred by another medical
practitioner) (OP) ......... 4.30 4.30 4.30 4.30 4.30
4.30
1008 Two procedures to which Item
1006 applies (SP) .......... 6.90 6.90 6.90 6.90 6.90
6.90
1009 Two procedures to which Item
1007 applies (OP) .......... 5.20 5.20 5.20 5.20 5.20
5.20
1011 Three or more procedures to
which Item 1006 applies
including calculation of
erythrocyte indices where
done (SP) .................. 10.35 10.35 10.35 10.35 10.35 10.35
1012 Three or more procedures to
which Item 1007 applies
including calculation of
erythrocyte indices where
done (OP) .................. 7.80 7.80 7.80 7.80 7.80
7.80
1014 Blood film, examination of,
including erythrocyte
morphology, differential
count by one or more methods
and the qualitative
estimation of platelets (SP) 8.55 8.55 8.55 8.55 8.55
8.55
1015 Blood film, examination of,
including erythrocyte
morphology, differential
count by one or more methods
and the qualitative
estimation of platelets
(OP) ....................... 6.45 6.45 6.45 6.45 6.45
6.45
1019 Blood film, examination by
special stains to demonstrate
the presence of basophilic
stippling, eosinophils (where
wet preparation or film is
used), haemoglobin H,
reticulocytes, or similar
conditions, cells or
substances-one procedure (SP)
........................... 4.60 4.60 4.60 4.60 4.60
4.60 1020 Blood film, examination by
special stains to demonstrate
the presence of basophilic
stippling, eosinophils (where
wet preparation or film is
used), haemoglobin H,
reticulocytes, or similar
conditions, cells or
substances-one procedure (OP)
........................... 3.45 3.45 3.45 3.45 3.45
3.45
1021 Two or more procedures to
which Item 1019 applies (SP)
........................... 6.90 6.90 6.90 6.90 6.90
6.90
1022 Two or more procedures to
which Item 1020 applies (OP)
........................... 5.20 5.20 5.20 5.20 5.20
5.20
1028 Blood film, examination by
special stains to demonstrate
the presence of foetal
haemoglobin, Heinz bodies,
iron, malarial or other
parasites, neutrophil
alkaline phosphatase, PAS,
Sudan black positive
granules, sickle cells, or
any similar cells, substances
or parasites-one procedure
(SP) ...................... 6.90 6.90 6.90 6.90 6.90
6.90
1029 Blood film, examination by
special stains to demonstrate
the presence of foetal
haemoglobin, Heinz bodies,
iron, malarial or other
parasites, neutrophil
alkaline phosphatase, PAS,
Sudan black positive
granules, sickle cells, or
any similar cells, substances
or parasites-one procedure
(OP) ...................... 5.20 5.20 5.20 5.20 5.20
5.20
1030 Two or more procedures to
which Item 1028 applies (SP)
........................... 11.40 11.40 11.40 11.40 11.40 11.40
1032 Two or more procedures to
which Item 1029 applies (OP)
........................... 8.55 8.55 8.55 8.55 8.55
8.55
1036 Erythrocytes, qualitative
assessment of metabolism or
haemolysis by-erythrocyte
autohaemolysis test,
erythrocyte fragility test
(mechanical) ,
glucose-6-phosphate
dehydrogenase estimation,
glutathione deficiencies
test, pyruvate kinase
estimation or sugar water
test (or similar) for
paroxysmal nocturnal
haemoglobinuria-one procedure
(SP) ....................... 11.40 11.40 11.40 11.40 11.40
11.40
1037 Erythrocytes, qualitative
assessment of metabolism or
haemolysis by-erythrocyte
autohaemolysis test,
erythrocyte fragility test
(mechanical) ,
glucose-6-phosphate
dehydrogenase estimation,
glutathione deficiencies
test, pyruvate kinase
estimation or sugar water
test (or similar) for
paroxysmal nocturnal
haemoglobinuria-one procedure
(OP) 8.55 8.55 8.55 8.55 8.55
8.55
1038 Two or more procedures to
which Item 1036 applies
(SP) ....................... 23.00 23.00 23.00 23.00 23.00
23.00
1040 Two or more procedures to
which Item 1037 applies
(OP) ....................... 17.25 17.25 17.25 17.25 17.25
17.25
1044 Erythrocytes, quantitative
assessment of metabolism or
haemolysis by-acid haemolysis
test (or similar) for
paroxysmal nocturnal
haemoglobinuria, erythrocyte
fragility to hypotonic saline
test without incubation,
erythrocyte fragility to
hypotonic saline test after
incubation, glutathione
stability test,
glucose-6-phosphate
dehydrogenase estimation, or
pyruvate kinase
estimation-one procedure
(SP) ....................... 23.00 23.00 23.00 23.00 23.00
23.00
1045 Erythrocytes, quantitative
assessment of metabolism or
haemolysis by-acid haemolysis
test (or similar) for
paroxysmal nocturnal
haemoglobinuria, erythrocyte
fragility to hypotonic saline
test without incubation,
erythrocyte fragility to
hypotonic saline test after
incubation, glutathione
stability test,
glucose-6-phosphate
dehydrogenase estimation, or
pyruvate kinase
estimation-one procedure
(OP) ....................... 17.25 17.25 17.25 17.25 17.25
17.25
1048 Two or more procedures to
which Item 1044 applies
(SP) ....................... 46.00 46.00 46.00 46.00 46.00
46.00
1049 Two or more procedures to
which Item 1045 applies
(OP) ....................... 34.50 34.50 34.50 34.50 34.50
34.50
1052 Viscosity of plasma or whole
blood, estimation of-each
procedure (SP) ............. 9.10 9.10 9.10 9.10 9.10
9.10
1053 Viscosity of plasma or whole
blood, estimation of-each
procedure (OP) ............. 6.90 6.90 6.90 6.90 6.90
6.90
Bone Marrow Examination
1062 Bone marrow examination
(including use of special
stains where indicated) of
bone marrow aspirate, clot
section or trephine
section-one procedure (SP) . 69.00 69.00 69.00 69.00 69.00 69.00
1063 Bone marrow examination
(including use of special
stains where indicated) of
bone marrow aspirate, clot
section or trephine
section-one procedure (OP) 51.75 51.75 51.75 51.75 51.75
51.75
1064 Two or more procedures to
which Item 1062 applies
(SP) ....................... 114.00 114.00 114.00 114.00
114.00 114.00
1065 Two or more procedures to
which Item 1063 applies
(OP) ....................... 85.50 85.50 85.50 85.50 85.50
85.50
Blood Transfusion Procedures
1080 Blood grouping (including
back grouping when
performed)-ABO and Rh (D
antigen) (not covered by Item
1089) (SP) ................. 11.40 11.40 11.40 11.40 11.40 11.40
1081 Blood grouping (including
back grouping when
performed)-ABO and Rh (D
antigen) (not covered by Item
1090) (OP) ................. 8.55 8.55 8.55 8.55 8.55
8.55
1089 Blood grouping (including
back grouping when
performed)-ABO and Rh (D
antigen) when performed in
association with the
compatability testing covered
by Item 1112 or 1114 (SP) .. 20.50 20.50 20.50 20.50 20.50 20.50
1090 Blood grouping (including
back grouping when
performed)-ABO and Rh (D
antigen) when performed in
association with the
compatability testing covered
by Item 1113 or 1116 (OP) .. 15.40 15.40 15.40 15.40 15.40 15.40
1101 Blood grouping-Rh phenotypes,
Kell system, Duffy system, M
and N factors or any other
blood group system-one system
(SP) ....................... 23.00 23.00 23.00 23.00 23.00
23.00
1102 Blood grouping-Rh phenotypes,
Kell system, Duffy system, M
and N factors or any other
blood group system-one system
(OP) ....................... 17.25 17.25 17.25 17.25 17.25
17.25
1104 Two procedures to which Item
1101 applies (SP) .......... 46.00 46.00 46.00 46.00 46.00 46.00
1105 Two procedures to which Item
1102 applies (OP) .......... 34.50 34.50 34.50 34.50 34.50 34.50
1106 Each procedure to which Item
1101 applies in excess of two
(SP) ....................... 11.40 11.40 11.40 11.40 11.40
11.40
1108 Each procedure to which Item
1102 applies in excess of two
(OP) ....................... 8.55 8.55 8.55 8.55 8.55
8.55
1111 Compatability testing by
saline, papain, albumin or
indirect Coombs techniques
(by one or more of those
techniques), including
auto-cross-match and donor
group check where
performed-testing involving
one or two units of blood
(SP) ....................... 34.50 34.50 34.50 34.50 34.50
34.50 1112 Compatability testing by
saline, papain, albumin or
indirect Coombs techniques
(by one or more of those
techniques), including
auto-cross-match and donor
group check where performed-
testing involving one or two
units of blood (OP).......... 25.90 25.90 25.90 25.90 25.90 25.90 1114
Compatability testing by
saline, papain, albumin or
indirect Coombs techniques
(by one or more of those
techniques), including
auto-cross-match and donor
group check where performed-
each unit of blood tested in
excess of two (SP).......... 12.90 12.90 12.90 12.90 12.90 12.90
1116 Compatability testing by saline,
papain, albumin or indirect Coombs
techniques (by one or more of those
techniques), including auto-cross-
match and donor group check where
performed - each unit of blood tested
in excess of two (OP)........ 9.70 9.70 9.70 9.70 9.70 9.70
1121 Examination of serum for Rh
antibodies or other blood group
antibodies- screening test (by one
or more of those techniques) (SP).17.20 17.20 17.20 17.20 17.20 17.20 1122
Examination of serum for Rh
antibodies or other blood group
antibodies or both Rh antibodies
and other blood group antibodies
- screening test (by one or more
of those techniques) (OP)...... 12.90 12.90 12.90 12.90 12.90 12.90 1124
Examination of serum for Rh
antibodies or other blood group
antibodies or both Rh antibodies
- screening test (by one or more
of those techniques) and quanti-
tative estimation of one antibody
(SP) .......................... 46.00 46.00 46.00 46.00 46.00
46.00 1125 Examination of serum for Rh
antibodies or other blood group
antibodies or both Rh antibodies
and other blood group antibodies
- screening test (by one or more
of those techniques) and
quantitative estimation of one
antibody (OP) ................. 34.50 34.50 34.50 34.50 34.50 34.50 1126
Examination of serum for
Rh antibodies or other
blood group antibodies or
both Rh antibodies and other
other blood group antibodies-
quantitative estimation of
one antibody (SP) ............. 34.50 34.50 34.50 34.50 34.50 34.50 1128
Examination of serum for Rh
antibodies or other blood
group antibodies or both Rh
antibodies and other blood
group antibodies - quantitative
estimation of one antibody (OP) 25.90 25.90 25.90 25.90 25.90 25.90 1129
Examination of serum for Rh
antibodies or other blood
group antibodies or both Rh
antibodies and other blood
group antibodies - quantitative
estimation of each antibody in
excess of one (SP)........... 23.00 23.00 23.00 23.00 23.00 23.00 1130
Examination of serum for Rh
antibodies or other blood group
antibodies or both Rh antibodies
and other blood group antibodies
- quantitative estimation of each
antibody in excess of one (OP). 17.25 17.25 17.25 17.25 17.25 17.25 1136
Coombs test, direct (SP) ...... 11.40 11.40 11.40 11.40 11.40 11.40 1137
Coombs test, direct (OP) ...... 8.55 8.55 8.55 8.55 8.55 8.55 1144 Coombs
test, indirect (not
associated with Item 1112,
1114, 1121, 1124, 1126 or
1129, except where part of
neo-natal screening or in
investigation of haemolytic
anaemia) (SP) ................ 17.20 17.20 17.20 17.20 17.20 17.20 1145 Coombs
test, indirect (not
associated with Item 1113,
1116, 1122, 1125, 1128 or
1130, except where part of
neo-natal screening or in
investigation of haemolytic
anaemia) (OP) .............. 12.90 12.90 12.90 12.90 12.90 12.90
1152 Examination of serum for blood
group haemolysins (SP) ..... 23.00 23.00 23.00 23.00 23.00 23.00
1153 Examination of serum for blood
group haemolysins (OP) ...... 17.25 17.25 17.25 17.25 17.25 17.25 1159
Leucocyte agglutinins,
detection of (SP) ............ 23.00 23.00 23.00 23.00 23.00 23.00 1160
Leucocyte
agglutinins, detection of (OP) 17.25 17.25 17.25 17.25 17.25 17.25 1166
Platelet
agglutinins, detection of (SP) 23.00 23.00 23.00 23.00 23.00 23.00 1167
Platelet
agglutinins, detection of (OP). 17.25 17.25 17.25 17.25 17.25 17.25
Miscellaneous 1190 Heterophile antibodies
-qualitative estimation of (test
for infectious mono-nucleosis) (SP). 9.20 9.20 9.20 9.20 9.20 9.20 1191
Heterophile antibodies-
qualitative estimation of (test
for infectious mono- nucleosis) (OP) 6.90 6.90 6.90 6.90 6.90 6.90 1194
Heterophile antibodies-
quantitative estimation of
by serial dilutions with
specific absorption (including
qualitative estimation covered
by Item 1190 where performed) (SP) 23.00 23.00 23.00 23.00 23.00 23.00
1195 Heterophile
antibodies-quantitative
estimation of by serial
dilutions with specific
absorption (including
qualitative estimation
covered by Item 1191 where
performed) (OP) ............ 17.25 17.25 17.25 17.25 17.25 17.25
1202 Cold agglutinins,
quantitative estimation of
(SP) ....................... 9.20 9.20 9.20 9.20 9.20
9.20
1203 Cold agglutinins,
quantitative estimation of
(OP) ....................... 6.90 6.90 6.90 6.90 6.90
6.90
1206 Cold agglutinins,
quantitative estimation of by
serial dilutions (including
qualitative estimation
covered by Item 1202 where
performed) (SP) ............ 23.00 23.00 23.00 23.00 23.00 23.00
1207 Cold agglutinins,
quantitative estimation of by
serial dilutions (including
qualitative estimation
covered by Item 1203 where
performed) (OP) ............ 17.25 17.25 17.25 17.25 17.25 17.25
1211 Blood volume, estimation of
by dye method (SP) ......... 11.40 11.40 11.40 11.40 11.40 11.40
1212 Blood volume, estimation of
by dye method (OP) ......... 8.55 8.55 8.55 8.55 8.55
8.55
1215 Blood, spectroscopic
examination of (SP) ........ 11.40 11.40 11.40 11.40 11.40 11.40
1216 Blood, spectroscopic
examination of (OP) ........ 8.55 8.55 8.55 8.55 8.55
8.55
Haemostasis
1234 Estimation of-bleeding time;
coagulation time (including
clot retraction); prothrombin
time (one stage);
thromboplastin time (partial)
with or without kaolin and
with or without kaolin
clotting time; or thrombotest
(Owren)-one procedure (SP) . 11.40 11.40 11.40 11.40 11.40 11.40
1235 Estimation of-bleeding time;
coagulation time (including
clot retraction); prothrombin
time (one stage);
thromboplastin time (partial)
with or without kaolin and
with or without kaolin
clotting time; or thrombotest
(Owren)-one procedure (OP) . 8.55 8.55 8.55 8.55 8.55
8.55
1236 Two procedures to which Item
1234 applies (SP) .......... 17.20 17.20 17.20 17.20 17.20 17.20
1237 Two procedures to which Item
1235 applies (OP) .......... 12.90 12.90 12.90 12.90 12.90 12.90
1238 Three or more procedures to
which Item 1234 applies
(SP) ....................... 23.00 23.00 23.00 23.00 23.00
23.00
1239 Three or more procedures to
which Item 1235 applies
(OP) ....................... 17.25 17.25 17.25 17.25 17.25
17.25
1242 Platelet aggregation,
qualitative test for (SP) .. 11.40 11.40 11.40 11.40 11.40 11.40
1243 Platelet aggregation,
qualitative test for (OP) .. 8.55 8.55 8.55 8.55 8.55
8.55
1244 Estimation of thrombin time
(including test for presence
of an inhibitor and serial
test for fibrinogenolysis) or
recalcified plasma clotting
time-each procedure (SP) ... 11.40 11.40 11.40 11.40 11.40 11.40
1246 Estimation of thrombin time
(including test for presence
of an inhibitor and serial
test for fibrinogenolysis) or
recalcified plasma clotting
time-each procedure (OP) ... 8.55 8.55 8.55 8.55 8.55
8.55
1247 Fibrinogen titre,
determination of (SP) ...... 11.40 11.40 11.40 11.40 11.40 11.40
1248 Fibrinogen titre,
determination of (OP) ...... 8.55 8.55 8.55 8.55 8.55
8.55
1251 Factor 13, test for presence
of (SP) .................... 17.20 17.20 17.20 17.20 17.20 17.20
1252 Factor 13, test for presence
of (OP) .................... 12.90 12.90 12.90 12.90 12.90 12.90
1255 Thromboplastin generation
screening test (SP) ........ 17.20 17.20 17.20 17.20 17.20 17.20
1256 Thromboplastin generation
screening test (OP) ........ 12.90 12.90 12.90 12.90 12.90 12.90
1259 Prothrombin time, estimation
of (two stage) (SP) ........ 17.20 17.20 17.20 17.20 17.20 17.20
1260 Prothrombin time, estimation
of (two stage) (OP) ........ 12.90 12.90 12.90 12.90 12.90 12.90
1261 Qualitative, quantitative or
qualitative and quantitative
estimation of fibrin
degeneration products (SP) . 13.80 13.80 13.80 13.80 13.80 13.80
1262 Qualitative, quantitative or
qualitative and quantitative
estimation of fibrin
degeneration products (OP) . 10.35 10.35 10.35 10.35 10.35 10.35
1263 Quantitative estimation
of-platelet adhesion,
prothrombin consumption or
protamine sulphate-each
procedure (SP) ............. 17.20 17.20 17.20 17.20 17.20 17.20
1264 Quantitative estimation
of-platelet adhesion,
prothrombin consumption or
protamine sulphate-each
procedure (OP) ............. 12.90 12.90 12.90 12.90 12.90 12.90
1267 Euglobulin lysis time,
estimation of (SP) ......... 34.50 34.50 34.50 34.50 34.50 34.50
1268 Euglobulin lysis time,
estimation of (OP) 25.90 25.90 25.90 25.90 25.90
25.90
1271 Quantitative estimation of
platelet antibodies (by one
or more techniques), platelet
Factor III availability or
one or more blood coagulation
factors (including
antihaemophilic
globulin)-each procedure
(SP) ....................... 34.50 34.50 34.50 34.50 34.50
34.50
1272 Quantitative estimation of
platelet antibodies (by one
or more techniques), platelet
Factor III availability or
one or more blood coagulation
factors (including
antihaemophilic
globulin)-each procedure
(OP) ....................... 25.90 25.90 25.90 25.90 25.90
25.90
1277 Platelet aggregation test
using-ADP, collagen, 5HT,
ristocetin, or similar
substance-one procedure
(SP) ....................... 34.50 34.50 34.50 34.50 34.50
34.50
1278 Platelet aggregation test
using-ADP, collagen, 5HT,
ristocetin, or similar
substance-one procedure (OP)
........................... 25.90 25.90 25.90 25.90 25.90 25.90
1279 Two or more procedures to
which Item 1277 applies (SP)
........................... 69.00 69.00 69.00 69.00 69.00 69.00
1280 Two or more procedures to
which Item 1278 applies (OP)
........................... 51.75 51.75 51.75 51.75 51.75 51.75
Division 2-Chemistry of Body Fluids and Tissues
1296 Quantitative estimation of
any substance by reagent
strip with reflectance meter
(not associated with Items
1301 to 1312) by or on behalf
of an approved pathology
practitioner where the
patient is referred by a
medical practitioner for the
estimation and where the
referring medical
practitioner is not a member
of a group of practitioners
of which the first-mentioned
practitioner is a member-one
or more estimations (SP) .. 12.90 12.90 12.90 12.90 12.90 12.90
1297 Quantitative estimation of
any substance by reagent
strip with reflectance meter
(not associated with Items
1301 to 1312) by or on behalf
of an approved pathology
practitioner where the
patient is referred by a
medical practitioner for the
estimation and where the
referring medical
practitioner is not a member
of a group of practitioners
of which the first-mentioned
practitioner is a member-one
or more estimations (OP) .. 9.70 9.70 9.70 9.70 9.70
9.70
1301 Estimation by any method,
except by reagent strip with
or without reflectance meter,
of-albumin; alkaline
phosphatase; ALT; AST;
bicarbonate; bilirubin
(direct) ; bilirubin
(indirect); calcium
(including serum ionized
calcium); chloride;
cholesterol; CK; CK
isoenzymes; creatinine; GGTP;
globulin; glucose; HBD; LD;
phosphate; potassium; protein
(total) ; sodium;
triglycerides; urate or urea
or estimation of a substance
referred to in any other item
in this Division other than
Items 1302 and 1303 where the
estimation is performed on a
multichannel analyser-one
estimation (SP) ............ 12.90 12.90 12.90 12.90 12.90 12.90
1302 Estimation by any method,
except by reagent strip with
or without reflectance meter,
of-albumin; alkaline
phosphatase; ALT; AST;
bicarbonate; bilirubin
(direct) ; bilirubin
(indirect); calcium
(including serum ionized
calcium); chloride;
cholesterol; CK; CK
isoenzymes; creatinine; GGTP;
globulin; glucose; HBD; LD;
phosphate; potassium; protein
(total) ; sodium;
triglycerides; urate or urea
or estimation of a substance
referred to in any other item
in this Division other than
Items 1301 and 1303 where the
estimation is performed on a
multichannel analyser-one
estimation (OP) ............ 9.70 9.70 9.70 9.70 9.70
9.70
1304 Two estimations of a kind
specified in Item 1301 (SP) 17.25 17.25 17.25 17.25 17.25
17.25
1305 Two estimations of a kind
specified in Item 1302 (OP) 12.95 12.95 12.95 12.95 12.95
12.95
1307 Three to five estimations of
a kind specified in Item 1301
(SP) ....................... 21.40 21.40 21.40 21.40 21.40
21.40
1308 Three to five estimations of
a kind specified in Item 1302
(OP) ....................... 16.05 16.05 16.05 16.05 16.05
16.05
1310 Six or more estimations of a
kind specified in Item 1301
(SP) ....................... 23.65 23.65 23.65 23.65 23.65
23.65
1311 Six or more estimations of a
kind specified in Item 1302
(OP) ....................... 17.75 17.75 17.75 17.75 17.75
17.75
1313 Glycosylated haemoglobin,
estimation of, in the
management of established
diabetes, with a maximum of
three estimations in any
twelve month period (SP) ... 20.50 20.50 20.50 20.50 20.50 20.50
1314 Glycosylated haemoglobin,
estimation of, in the
management of established
diabetes, with a maximum of
three estimations in any
twelve month period (OP) ... 15.40 15.40 15.40 15.40 15.40 15.40
1319 Qualitative estimation
of-acidity (by pH meter or
titration), blood in faeces
(occult blood),
cryoglobulins, cryoproteins,
euglobulins, macroglobulins
(Sia test), PBG, protein
(Bence-Jones) in urine, UBG
or any other substance not
specified in any other item
in this Division-one
estimation (SP) ............ 5.70 5.70 5.70 5.70 5.70
5.70
1320 Qualitative estimation
of-acidity (by pH meter or
titration), blood in faeces
(occult blood),
cryoglobulins, cryoproteins,
euglobulins, macroglobulins
(Sia test), PBG, protein
(Bence-Jones) in urine, UBG
or any other substance not
specified in any other item
in this Division-one
estimation (OP) ............ 4.30 4.30 4.30 4.30 4.30
4.30
1322 Two or more estimations to
which Item 1319 applies
(SP) ....................... 11.40 11.40 11.40 11.40 11.40
11.40
1323 Two or more estimations to
which Item 1320 applies
(OP) ....................... 8.55 8.55 8.55 8.55 8.55
8.55
1324 Quantitative estimation of
blood gases (including pO2,
oxygen saturation, PCO2 and
estimation of bicarbonate and
pH) (SP) ................... 34.50 34.50 34.50 34.50 34.50 34.50
1325 Quantitative estimation of
blood gases (including pO2,
oxygen saturation, PCO2 and
estimation of bicarbonate and
pH) (OP) ................... 25.90 25.90 25.90 25.90 25.90 25.90
1327 Qualitative estimation
of-foetoprotein, gastric
acidity (by dye method) or
porphyrins-each estimation
(SP) ....................... 23.00 23.00 23.00 23.00 23.00
23.00
1328 Qualitative estimation
of-foetoprotein, gastric
acidity (by dye method) or
porphyrins-each estimation
(OP) ....................... 17.25 17.25 17.25 17.25 17.25
17.25
1330 Chromatography, qualitative
estimation of a substance not
specified in any other item
in this Division (SP) ...... 23.00 23.00 23.00 23.00 23.00 23.00
1331 Chromatography, qualitative
estimation of a substance not
specified in any other item
in this Division (OP) ...... 17.25 17.25 17.25 17.25 17.25 17.25
1333 Electrophoresis, qualitative
(SP) ....................... 23.00 23.00 23.00 23.00 23.00
23.00
1334 Electrophoresis, qualitative
(OP) ....................... 17.25 17.25 17.25 17.25 17.25
17.25
1336 Australia antigen or similar
antigen, detection of by any
method including
radioimmunoassay (SP) ...... 23.00 23.00 23.00 23.00 23.00 23.00
1337 Australia antigen or similar
antigen, detection of by any
method including
radioimmunoassay (OP) ...... 17.25 17.25 17.25 17.25 17.25 17.25
1339 Osmolality, estimation of in
serum or urine (SP) ........ 23.00 23.00 23.00 23.00 23.00 23.00
1340 Osmolality, estimation of in
serum or urine (OP) ........ 17.25 17.25 17.25 17.25 17.25 17.25
1342 Quantitative estimation
of-acid phosphatase,
aldolase, alpha
foeto-proteins in serum,
amylase, lipase, amylase and
lipase, antithrombin 3,
antitrypsin alpha-1, bromide,
BSP, caeruloplasmin,
carotene, complement (total
or fraction), any other
specific protein (excluding
immunoglobulins) (where
estimated by immunodiffusion,
nephelometry, Laurell rocket
or similar technique),
creatine, cryofibrinogen,
haemoglobin F, hexosamine,
lactate, lithium, magnesium,
pyruvate, salicylate or
xylose-each estimation (SP) 23.00 23.00 23.00 23.00 23.00
23.00
1343 Quantitative estimation
of-acid phosphatase,
aldolase, alpha
foeto-proteins in serum,
amylase, lipase, amylase and
lipase, antithrombin 3,
antitrypsin alpha-1, bromide,
BSP, caeruloplasmin,
carotene, complement (total
or fraction), any other
specific protein (excluding
immunoglobulins) (where
estimated by immunodiffusion,
nephelometry, Laurell rocket
or similar technique),
creatine, cryofibrinogen,
haemoglobin F, hexosamine,
lactate, lithium, magnesium,
pyruvate, salicylate or
xylose-each estimation (OP) 17.25 17.25 17.25 17.25 17.25
17.25
1345 Quantitative estimation
of-arsenic, copper, gold,
lead, mercury, strontium,
zinc, any other element not
specified in any other item
in this Division, folic acid,
vitamin B12, any other
vitamin not specified in any
other item in this Division,
alcohol, ammonia, neo-natal
bilirubin (direct and
indirect), cholinesterase,
coproporphyrin,
erythroporphyrin,
uroporphyrin or any other
porphyrin factor,
carboxyhaemoglobin, delta
ALA, 5HIAA, iron (including
iron-binding capacity),
oxalate, oxosteroids,
oxogenic steroids, PBG, urine
oestriol, transketolase or
any other substance not
specified in any other item
in this Division-each
estimation (SP) ............ 34.50 34.50 34.50 34.50 34.50 34.50
1346 Quantitative estimation
of-arsenic, copper, gold,
lead, mercury, strontium,
zinc, any other element not
specified in any other item
in this Division, folic acid,
vitamin B12, any other
vitamin not specified in any
other item in this Division,
alcohol, ammonia, neo-natal
bilirubin (direct and
indirect), cholinesterase,
coproporphyrin,
erythroporphyrin,
uroporphyrin or any other
porphyrin factor,
carboxyhaemoglobin, delta
ALA, 5HIAA, iron (including
iron-binding capacity),
oxalate, oxosteroids,
oxogenic steroids, PBG, urine
oestriol, transketolase or
any other substance not
specified in any other item
in this Division-each
estimation (OP) ............ 25.90 25.90 25.90 25.90 25.90 25.90
1348 Dibucaine number or similar,
determination of (SP) ...... 34.50 34.50 34.50 34.50 34.50 34.50
1349 Dibucaine number or similar,
determination of (OP) ...... 25.90 25.90 25.90 25.90 25.90 25.90
1351 Indican, qualitative test for
(SP) ....................... 34.50 34.50 34.50 34.50 34.50
34.50
1352 Indican, qualitative test for
(OP) ....................... 25.90 25.90 25.90 25.90 25.90
25.90
1354 Calculus, analysis of (SP) . 34.50 34.50 34.50 34.50 34.50 34.50
1355 Calculus, analysis of (OP) . 25.90 25.90 25.90 25.90 25.90 25.90
1357 Amniotic fluid
spectrophotometric analysis
of (SP) .................... 34.50 34.50 34.50 34.50 34.50 34.50
1358 Amniotic fluid
spectrophotometric analysis
of (OP) .................... 25.90 25.90 25.90 25.90 25.90 25.90
1360 Electrophoresis, quantitative
(including quantitative test)
(SP) ....................... 34.50 34.50 34.50 34.50 34.50
34.50
1362 Electrophoresis, quantitative
(including quantitative test)
(OP) ....................... 25.90 25.90 25.90 25.90 25.90
25.90
1364 Quantitative estimation
of-catecholamines (one or
more components), faecal fat,
HMMA, hydroxyproline,
non-pregnancy oestrogens,
pregnanediol, pregnanetriol,
any other steroid fraction
(where not estimated in the
same process as another
steroid fraction) or multiple
steroid fractions estimated
in the same process-each
estimation (SP) ............ 46.00 46.00 46.00 46.00 46.00 46.00
1366 Quantitative estimation
of-catecholamines (one or
more components), faecal fat,
HMMA, hydroxyproline,
non-pregnancy oestrogens,
pregnanediol, pregnanetriol,
any other steroid fraction
(where not estimated in the
same process as another
steroid fraction) or multiple
steroid fractions estimated
in the same process-each
estimation (OP) ............ 34.50 34.50 34.50 34.50 34.50 34.50
1368 Chromatography, quantitative
estimation (including
qualitative test) of any
substance not specified in
any other item in this
Division (SP) .............. 46.00 46.00 46.00 46.00 46.00 46.00
1370 Chromatography, quantitative
estimation (including
qualitative test) of any
substance not specified in
any other item in this
Division (OP) .............. 34.50 34.50 34.50 34.50 34.50 34.50
1372 Lecithin/sphyingomyelin ratio
of amniotic fluid,
determination of (SP) ...... 46.00 46.00 46.00 46.00 46.00 46.00
1374 Lecithin/sphyingomyelin ratio
of amniotic fluid,
determination of (OP) ...... 34.50 34.50 34.50 34.50 34.50 34.50
1376 Drug assays-qualitative
estimations or screenings
procedures, by colorimetric
methods-one or more
estimations or procedures on
each specimen (SP) ......... 11.40 11.40 11.40 11.40 11.40 11.40
1378 Drug assays-qualitative
estimations or screenings
procedures, by colorimetric
methods-one or more
estimations or procedures on
each specimen (OP) ......... 8.55 8.55 8.55 8.55 8.55
8.55
1380 Assay by radioimmunoassay,
enzyme linked immunoassay,
gas liquid chromatography or
any other method of
barbiturates, carbamazepine,
digoxin or
phenytoin-estimation of one
substance by one or more
methods (SP) ............... 28.50 28.50 28.50 28.50 28.50 28.50
1381 Assay by radioimmunoassay,
enzyme linked immunoassay,
gas liquid chromatography or
any other method of
barbiturates, carbamazepine,
digoxin or
phenytoin-estimation of one
substance by one or more
methods (OP) ............... 21.40 21.40 21.40 21.40 21.40 21.40
1382 Estimation of two substances
referred to in Item 1380 by
using one or more of the
methods specified in that
item in relation to each
(SP) ....................... 46.00 46.00 46.00 46.00 46.00
46.00
1384 Estimation of two substances
referred to in Item 1381 by
using one or more of the
methods specified in that
item in relation to each
(OP) ....................... 34.50 34.50 34.50 34.50 34.50
34.50
1385 Estimation of three or more
substances referred to in
Item 1380 by using one or
more of the methods specified
in that item in relation to
each (SP) .................. 57.00 57.00 57.00 57.00 57.00 57.00
1387 Estimation of three or more
substances referred to in
Item 1381 by using one or
more of the methods specified
in that item in relation to
each (OP) .................. 42.75 42.75 42.75 42.75
. 42.75
42.75
1392 Assay by radioimmunoassay,
enzyme linked immunoassay,
gas liquid chromatography or
any other method of diazepam,
ethosuximide, methotrexate,
morphine, procainamide,
quinidine or a similar
substance not referred to in
any item in this Division,
other than this item and Item
1393-estimation of one
substance by one or more
methods (SP) ............... 34.50 34.50 34.50 34.50 34.50 34.50
1393 Assay by radioimmunoassay,
enzyme linked immunoassay,
gas liquid chromatography or
any other method of diazepam,
ethosuximide, methotrexate,
morphine, procainamide,
quinidine or a similar
substance not referred to in
any item in this Division,
other than this item and Item
1392-estimation of one
substance by one or more
methods (OP) ............... 25.90 25.90 25.90 25.90 25.90 25.90
1394 Estimation of two substances
referred to in Item 1392 by
using one or more of the
methods specified in that
item in relation to each
(SP) ....................... 57.00 57.00 57.00 57.00 57.00
57.00
1395 Estimation of two substances
referred to in Item 1393 by
using one or more of the
methods specified in that
item in relation to each
(OP) ....................... 42.75 42.75 42.75 42.75 42.75
42.75
1397 Estimation of three or more
substances referred to in
Item 1392 by using one or
more of the methods specified
in that item in relation to
each (SP) .................. 69.00 69.00 69.00 69.00 69.00 69.00
1398 Estimation of three or more
substances referred to in
Item 1393 by using one or
more of the methods specified
in that item in relation to
each (OP) .................. 51.75 51.75 51.75 51.75 51.75 51.75
1401 HDL cholesterol, estimation
of, in proven cases of
hyperlipidaemia-two
estimations in any twelve
month period-each estimation
(SP) ....................... 23.00 23.00 23.00 23.00 23.00
23.00
1402 HDL cholesterol, estimation
of, in proven cases of
hyperlipidaemia-two
estimations in any twelve
month period-each estimation
(OP) ....................... 17.25 17.25 17.25 17.25 17.25
17.25
Hormone Assays not covered by any other item in this Division
1421 Assay of T3 resin uptake,
thyroxine (T4) or normalised
thyroxine (effective
thyroxine ratio)-using any
technique-one estimation
(SP) ....................... 17.20 17.20 17.20 17.20 17.20
17.20
1422 Assay of T3 resin uptake,
thyroxine (T4) or normalised
thyroxine (effective
thyroxine ratio)-using any
technique-one estimation
(OP) ....................... 12.90 12.90 12.90 12.90 12.90
12.90
1424 Assay of T3 resin uptake,
thyroxine (T4) or normalised
thyroxine (effective
thyroxine ratio)-using any
technique-two or more
estimations (SP) ........... 28.50 28.50 28.50 28.50 28.50 28.50
1425 Assay of T3 resin uptake,
thyroxine (T4) or normalised
thyroxine (effective
thyroxine ratio)-using any
technique-two or more
estimations (OP) ........... 21.40 21.40 21.40 21.40 21.40 21.40
1452 Hormone assays-assay of
insulin, growth hormone, TSH,
LH, FSH, T3, prolactin,
renin, gastrin, cortisol
(selenium labelled), ACTH,
HPL but not including assay
of a thyroid hormone covered
by Item 1421 or 1424, using
gamma emitting labels or
other unspecified
technique-one estimation of
any one hormone (SP) ....... 34.50 34.50 34.50 34.50 34.50 34.50
1453 Hormone assays-assay of
insulin, growth hormone, TSH,
LH, FSH, T3, prolactin,
renin, gastrin, cortisol
(selenium labelled), ACTH,
HPL but not including assay
of a thyroid hormone covered
by Item 1422 or 1425, using
gamma emitting labels or
other unspecified
technique-one estimation of
any one hormone (OP) ....... 25.90 25.90 25.90 25.90 25.90 25.90
1455 Two estimations of any one
hormone using any technique
referred to in Item 1452
(SP) ....................... 52.00 52.00 52.00 52.00 52.00
52.00
1456 Two estimations of any one
hormone using any technique
referred to in Item 1453
(OP) ....................... 39.00 39.00 39.00 39.00 39.00
39.00
1458 Three estimations of any one
hormone using any technique
referred to in Item 1452
(SP) ....................... 69.00 69.00 69.00 69.00 69.00
69.00
1459 Three estimations of any one
hormone using any technique
referred to in Item 1453
(OP) ....................... 51.75 51.75 51.75 51.75 51.75
51.75
1461 Each estimation of any one
hormone in excess of three
estimations using any
technique referred to in Item
1452 (SP) 6.90 6.90 6.90 6.90 6.90
6.90
1462 Each estimation of any one
hormone in excess of three
estimations using any
technique referred to in Item
1453 (OP) 5.20 5.20 5.20 5.20 5.20
5.20
1469 Hormone receptor assay on
proven primary breast
carcinoma or on subsequent
lesion in the breast-one or
more assays (SP) ........... 92.00 92.00 92.00 92.00 92.00 92.00
1470 Hormone receptor assay on
proven primary breast
carcinoma or on subsequent
lesion in the breast-one or
more assays (OP) ........... 69.00 69.00 69.00 69.00 69.00 69.00
1475 Hormone assays (including
assay of progesterone,
testosterone, cortisol
(tritium labelled),
17-hydroxyprogesterone,
oestradiol or aldosterone)
using beta emitting labels or
bioassay techniques-one
estimation of any one hormone
(SP) ....................... 57.00 57.00 57.00 57.00 57.00
57.00
1476 Hormone assays (including
assay of progesterone,
testosterone, cortisol
(tritium labelled),
17-hydroxyprogesterone,
oestradiol or aldosterone)
using beta emitting labels or
bioassay techniques-one
estimation of any one hormone
(OP) ....................... 42.75 42.75 42.75 42.75 42.75
42.75
1478 Hormone assay using beta
emitting labels or bioassay
techniques-two estimations of
any one hormone (SP) ....... 92.00 92.00 92.00 92.00 92.00 92.00
1479 Hormone assay using beta
emitting labels or bioassay
techniques-two estimations of
any one hormone (OP) ....... 69.00 69.00 69.00 69.00 69.00 69.00
1481 Hormone assay using beta
emitting labels or bioassay
techniques-three estimations
of any one hormone (SP) .... 114.00 114.00 114.00 114.00 114.00 114.00
1482 Hormone assay using beta
emitting labels or bioassay
techniques-three estimations
of any one hormone (OP) .... 85.50 85.50 85.50 85.50 85.50 85.50
1484 Hormone assay using beta
emitting labels or bioassay
techniques-each estimation of
any one hormone in excess of
three (SP) ................. 11.40 11.40 11.40 11.40 11.40 11.40
1485 Hormone assay using beta
emitting labels or bioassay
techniques-each estimation of
any one hormone in excess of
three (OP) ................. 8.55 8.55 8.55 8.55 8.55
8.55
Procedural Services
1504 Procedural service associated
with -ACTH stimulation test,
adrenaline tolerance test,
arginine infusion test,
bromsulphthalein test,
carbohydrate tolerance test,
creatinine clearance test,
gastric function test
requiring intubation,
glucagon tolerance test,
histidine loaded FIGLU test,
L-dopa stimulation test,
phenolsulphthalein excretion
test, TSH stimulation test
(other than the
administration of TSH), urea
clearance test, urea
concentration test,
vasopressin stimulation test,
xylose absorption test, or
any similar test (SP) ...... 11.40 11.40 11.40 11.40 11.40 11.40
1505 Procedural service associated
with -ACTH stimulation test,
adrenaline tolerance test,
arginine infusion test,
bromsulphthalein test,
carbohydrate tolerance test,
creatinine clearance test,
gastric function test
requiring intubation,
glucagon tolerance test,
histidine loaded FIGLU test,
L-dopa stimulation test,
phenolsulphthalein excretion
test, TSH stimulation test
(other than the
administration of TSH), urea
clearance test, urea
concentration test,
vasopressin stimulation test,
xylose absorption test, or
any similar test (OP) ...... 8.55 8.55 8.55 8.55 8.55
8.55
1511 Procedural services
associated with -tolbutamide
test, insulin hypoglycaemia
stimulation test,
gonadotrophin releasing
hormone stimulation test
(other than the
administration of
gonadotrophin releasing
hormone), thyrotrophin
releasing hormone stimulation
test (other than the
administration of thyroid
stimulating hormone), urine
acidification test, or any
similar test (SP) .......... 34.50 34.50 34.50 34.50 34.50 34.50
1512 Procedural services
associated with -tolbutamide
test, insulin hypoglycaemia
stimulation test,
gonadotrophin releasing
hormone stimulation test
(other than the
administration of
gonadotrophin releasing
hormone), thyrotrophin
releasing hormone stimulation
test (other than the
administration of thyroid
stimulating hormone), urine
acidification test, or any
similar test (OP) .......... 25.90 25.90 25.90 25.90 25.90 25.90
1516 Procedural services
associated with the
administration of
-thyrotrophin releasing
hormone, gonadotrophin
releasing hormone or thyroid
stimulating hormone (SP) ... 28.50 28.50 28.50 28.50 28.50 28.50
1517 Procedural services
associated with the
administration of
-thyrotrophin releasing
hormone, gonadotrophin
releasing hormone or thyroid
stimulating hormone (OP) ... 21.40 21.40 21.40 21.40 21.40 21.40
Division 3-Microbiology
1529 Microscopical examination,
wet film, not covered by Item
1536 (SP) .................. 6.90 6.90 6.90 6.90 6.90
6.90
1530 Microscopical examination,
wet film, not covered by Item
1537 (OP) .................. 5.20 5.20 5.20 5.20 5.20
5.20
1536 Microscopical examination of
urine and examination for one
or more of pH, specific
gravity, blood, albumin,
urobilinogen, sugar, acetone
and bile pigments (SP) ..... 9.20 9.20 9.20 9.20 9.20
9.20
1537 Microscopical examination of
urine and examination for one
or more of pH, specific
gravity, blood, albumin,
urobilinogen, sugar, acetone
and bile pigments (where the
patient is referred by
another medical practitioner)
(OP) 6.90 6.90 6.90 6.90 6.90
6.90
1545 Microscopical examination
using gram or similar stain
(e.g. Loeffler, methylene
blue, Giemsa)-one stain
(SP) ....................... 9.20 9.20 9.20 9.20 9.20
9.20
1546 Microscopical examination
using gram or similar stain
(e.g. Loeffler, methylene
blue, Giemsa)-one stain
(OP) ....................... 6.90 6.90 6.90 6.90 6.90
6.90
1548 Microscopical examination
using gram or similar stain
(e.g. Loeffler, methylene
blue, Giemsa)-two or more
stains (SP) ................ 11.40 11.40 11.40 11.40 11.40 11.40
1549 Microscopical examination
using gram or similar stain
(e.g. Loeffler, methylene
blue, Giemsa)-two or more
stains (OP) ................ 8.55 8.55 8.55 8.55 8.55
8.55
1556 Microscopical examination
using special stain (e.g.
Ziehl-Neelsen or similar
stain)-one stain (SP) ...... 11.40 11.40 11.40 11.40 11.40 11.40
1557 Microscopical examination
using special stain (e.g.
Ziehl-Neelsen or similar
stain)-one stain (OP) ...... 8.55 8.55 8.55 8.55 8.55
8.55
1566 Microscopical examination
using two or more stains, one
or more of which is a special
stain referred to in Item
1556 (SP) .................. 17.20 17.20 17.20 17.20 17.20 17.20
1567 Microscopical examination
using two or more stains, one
or more of which is a special
stain referred to in Item
1557 (OP) .................. 12.90 12.90 12.90 12.90 12.90 12.90
1586 Microscopical examination for
dermatophytes-examination of
material from one site (SP) 11.40 11.40 11.40 11.40 11.40
11.40
1587 Microscopical examination for
dermatophytes-examination of
material from one site (OP) 8.55 8.55 8.55 8.55 8.55
8.55
1588 Microscopical examination for
dermatophytes-examination of
material from two or more
sites (SP) ................. 23.00 23.00 23.00 23.00 23.00 23.00
1589 Microscopical examination for
dermatophytes-examination of
material from two or more
sites (OP) ................. 17.25 17.25 17.25 17.25 17.25 17.25
1604 Microscopical examination of
exudate by dark ground
illumination for Treponema
pallidum (SP) .............. 28.50 28.50 28.50 28.50 28.50 28.50
1606 Microscopical examination of
exudate by dark ground
illumination for Treponema
pallidum (OP) .............. 21.40 21.40 21.40 21.40 21.40 21.40
1609 Cultural examination of
material other than urine for
aerobic micro-organisms
(including fungi) with, where
indicated, the use of
relevant stains, selective
media or sensitivity testing
or any two or more of those
procedures-examination of
material from one site (SP) 17.25 17.25 17.25 17.25 17.25
17.25
1610 Cultural examination of
material other than urine for
aerobic micro-organisms
(including fungi) with, where
indicated, the use of
relevant stains, selective
media or sensitivity testing
or any two or more of those
procedures-examination of
material from one site (OP) 12.95 12.95 12.95 12.95 12.95
12.95
1612 Cultural examination of
material other than urine for
aerobic micro-organisms
(including fungi) with, where
indicated, the use of
relevant stains, selective
media or sensitivity testing
or any two or more of those
procedures-examination of
material from two or more
sites where processed
independently (SP) ......... 30.00 30.00 30.00 30.00 30.00 30.00
1613 Cultural examination of
material other than urine for
aerobic micro-organisms
(including fungi) with, where
indicated, the use of
relevant stains, selective
media or sensitivity testing
or any two or more of those
procedures-examination of
material from two or more
sites where processed
independently (OP) ......... 22.50 22.50 22.50 22.50 22.50 22.50
1615 Cultural examination of
material other than blood or
urine for aerobic and
anaerobic microorganisms
using an anaerobic atmosphere
for the culture of anaerobes,
with, where indicated, the
use of relevant stains,
selective media or
sensitivity testing or any
two or more of those
procedures-examination of
material from one site (SP) 25.90 25.90 25.90 25.90 25.90
25.90
1616 Cultural examination of
material other than blood or
urine for aerobic and
anaerobic micro-organisms
using an anaerobic atmosphere
for the culture of anaerobes,
with, where indicated, the
use of relevant stains,
selective media or
sensitivity testing or any
two or more of those
procedures-examination of
material from one site (OP) 19.45 19.45 19.45 19.45 19.45
19.45
1619 Cultural examination of
material other than blood or
urine for aerobic and
anaerobic micro-organisms
using an anaerobic atmosphere
for the culture of anaerobes,
with, where indicated, the
use of relevant stains,
selective media or
sensitivity testing or any
two or more of those
procedures-examination of
material from two or more
sites where processed
independently (SP) ......... 45.00 45.00 45.00 45.00 45.00 45.00
1620 Cultural examination of
material other than blood or
urine for aerobic and
anaerobic micro-organisms
using an anaerobic atmosphere
for the culture of anaerobes,
with, where indicated, the
use of relevant stains,
selective media or
sensitivity testing or any
two or more of those
procedures-examination of
material from two or more
sites where processed
independently (OP) ......... 33.75 33.75 33.75 33.75 33.75 33.75
1622 Cultural examination for
mycobacteria-each specimen
(SP) ....................... 23.00 23.00 23.00 23.00 23.00
23.00
1623 Cultural examination for
mycobacteria-each specimen
(OP) ....................... 17.25 17.25 17.25 17.25 17.25
17.25
1633 Blood culture, including
sub-culture, using both
aerobic and anaerobic media,
with, where indicated, the
use of relevant stains or
sensitivity testing or
relevant stains and
sensitivity testing, but not
involving organism
identification-each set of
cultures to a maximum of
three sets (SP) ............ 25.90 25.90 25.90 25.90 25.90 25.90
1634 Blood culture, including
sub-culture, using both
aerobic and anaerobic media,
with, where indicated, the
use of relevant stains or
sensitivity testing or
relevant stains and
sensitivity testing, but not
involving organism
identification-each set of
cultures to a maximum of
three sets (OP) ............ 19.45 19.45 19.45 19.45 19.45 19.45
1637 Screening test for mycoplasma
or ureaplasma or both (SP) . 5.70 5.70 5.70 5.70 5.70
5.70
1638 Screening test for mycoplasma
or ureaplasma or both (OP) . 4.30 4.30 4.30 4.30 4.30
4.30
1640 Coagulase test for organism
identification by slide or
tube method, not being a test
conducted in conjunction with
a service specified in Item
1644, 1647, 1661 or 1664 that
is performed for the purpose
of identifying the same
organism (SP) .............. 5.70 5.70 5.70 5.70 5.70
5.70
1641 Coagulase test for organism
identification by slide or
tube method, not being a test
conducted in conjunction with
a service specified in Item
1645, 1648, 1662 or 1665 that
is performed for the purpose
of identifying the same
organism (OP) .............. 4.30 4.30 4.30 4.30 4.30
4.30
1644 Identification of pathogenic
micro-organisms other than M
tuberculosis, using
biochemical tests or other
special techniques involving
sub-culture or biochemical
tests and other special
techniques involving
sub-culture-identification of
one organism (SP) .......... 11.40 11.40 11.40 11.40 11.40 11.40
1645 Identification of pathogenic
micro-organisms other than M
tuberculosis, using
biochemical tests or other
special techniques involving
sub-culture or biochemical
tests and other special
techniques involving
sub-culture-identification of
one organism (OP) .......... 8.55 8.55 8.55 8.55 8.55
8.55
1647 Identification of two or more
organisms, excluding M
tuberculosis, by the method
referred to in Item 1644
(SP) ....................... 23.00 23.00 23.00 23.00 23.00
23.00
1648 Identification of two or more
organisms, excluding M
tuberculosis, by the method
referred to in Item 1645
(OP) ....................... 17.25 17.25 17.25 17.25 17.25
17.25
1661 Identification of pathogenic
micro-organisms using a
serological technique
(including the
immunofluorescent or
immunoenxymic method)- a
procedure involving one
technique (SP) ............. 11.40 11.40 11.40 11.40 11.40 11.40
1662 Identification of pathogenic
micro-organisms using a
serological technique
(including the
immunofluorescent or
immunoenxymic method)- a
procedure involving one
technique (OP) ............. 8.55 8.55 8.55 8.55 8.55
8.55
1664 Two or more of any procedures
of a kind referred to in Item
1661 using different
techniques (SP) ............ 17.20 17.20 17.20 17.20 17.20 17.20
1665 Two or more of any procedures
of a kind referred to in Item
1662 using different
techniques (OP) ............ 12.90 12.90 12.90 12.90 12.90 12.90
1668 Anaerobic culture of urine
obtained by suprapubic
aspiration of the bladder
where previous aerobic urine
culture is negative, plus
microscopical examination of
urine, with cell count,
relevant stains (if
indicated), aerobic cultural
examination and colony count
of micro-organisms (not being
a service to which Item 1682
or 1683 applies), together
with sensitivity testing
(where indicated) and general
examination for one or more
of pH, specific gravity,
blood, albumin, urobilinogen,
sugar, acetone and bile
pigments (not covered by Item
1673, 1674 or 1676) (SP) ... 32.65 32.65 32.65 32.65 32.65 32.65
1669 Anaerobic culture of urine
obtained by suprapubic
aspiration of the bladder
where previous aerobic urine
culture is negative, plus
microscopical examination of
urine, with cell count,
relevant stains (if
indicated), aerobic cultural
examination and colony count
of micro-organisms (not being
a service to which Item 1682
or 1683 applies), together
with sensitivity testing
(where indicated) and general
examination for one or more
of pH, specific gravity,
blood, albumin, urobilinogen,
sugar, acetone and bile
pigments (not covered by Item
1673, 1674 or 1676) (OP) ... 24.50 24.50 24.50 24.50 24.50 24.50
1673 Microscopical examination of
urine, with cell count,
relevant stains (if
indicated), aerobic cultural
examination and colony count
of micro-organisms (other
than by simple microscopy and
simple culture, e.g. dip
slide and microbiological kit
tests covered by Item 1682),
with sensitivity testing and
testing for substances
inhibitory to microorganisms
where indicated and with
general examination for one
or more of the following
where indicated-pH, specific
gravity, blood, albumin,
urobilinogen, sugar, acetone
and bile pigments (SP) ..... 24.00 24.00 24.00 24.00 24.00 24.00
1674 Microscopical examination of
urine, with cell count,
relevant stains (if
indicated), aerobic cultural
examination and colony count
of micro-organisms (other
than by simple microscopy and
simple culture, e.g. dip
slide and microbiological kit
tests covered by Item 1682),
with sensitivity testing and
testing for substances
inhibitory to microorganisms
where indicated and with
general examination for one
or more of the following
where indicated-pH, specific
gravity, blood, albumin,
urobilinogen, sugar, acetone
and bile pigments (OP) ..... 18.00 18.00 18.00 18.00 18.00 18.00
1682 Microscopical examination of
urine and simple culture by
means of dip slide or
microbiological kit test
(where the patient is
referred by another medical
practitioner) (SP) ......... 11.40 11.40 11.40 11.40 11.40 11.40
1683 Microscopical examination of
urine and simple culture by
means of dip slide or
microbiological kit test
(where the patient is
referred by another medical
practitioner)(OP) .......... 8.55 8.55 8.55 8.55 8.55
8.55
1687 Microscopical examination of
faeces or body fluids for
parasites, cysts or ova, with
or without simple stains or
concentration techniques
(SP) ....................... 17.20 17.20 17.20 17.20 17.20
17.20
1688 Microscopical examination of
faeces or body fluids for
parasites, cysts or ova, with
or without simple stains or
concentration techniques
(OP) ....................... 12.90 12.90 12.90 12.90 12.90
12.90
1693 Identification of helminths
(SP) ....................... 11.40 11.40 11.40 11.40 11.40
11.40
1694 Identification of helminths
(OP) ....................... 8.55 8.55 8.55 8.55 8.55
8.55
1702 Cultural examination for
parasites, other than
trichomonas-culture of one
parasite (SP) .............. 23.00 23.00 23.00 23.00 23.00 23.00
1703 Cultural examination for
parasites, other than
trichomonas-culture of one
parasite (OP) .............. 17.25 17.25 17.25 17.25 17.25 17.25
1705 Cultural examination for
parasites, other than
trichomonas-culture of two or
more parasites (SP) ........ 40.00 40.00 40.00 40.00 40.00 40.00
1706 Cultural examination for
parasites, other than
trichomonas-culture of two or
more parasites (OP) ........ 30.00 30.00 30.00 30.00 30.00 30.00
1721 Determination of the minimum
inhibitory concentration of
an antibiotic or
chemotherapeutic agent by
tube technique or by agar
plate dilution-one organism
(SP) ....................... 23.00 23.00 23.00 23.00 23.00
23.00
1722 Determination of the minimum
inhibitory concentration of
an antibiotic or
chemotherapeutic agent by
tube technique or by agar
plate dilution-one organism
(OP) ....................... 17.25 17.25 17.25 17.25 17.25
17.25
1724 Determination of the minimum
inhibitory concentration of
an antibiotic or
chemotherapeutic agent by
tube technique or by agar
plate dilution-two or more
organisms (SP) ............. 28.50 28.50 28.50 28.50 28.50 28.50
1725 Determination of the minimum
inhibitory concentration of
an antibiotic or
chemotherapeutic agent by
tube technique or by agar
plate dilution-two or more
organisms (OP) ............. 21.40 21.40 21.40 21.40 21.40 21.40
1732 Detection of substances
inhibitory to micro-organisms
in a body fluid (excluding
urine)(SP) ................. 5.70 5.70 5.70 5.70 5.70
5.70
1733 Detection of substances
inhibitory to micro-organisms
in a body fluid (excluding
urine)(OP) ................. 4.30 4.30 4.30 4.30 4.30
4.30
1743 Quantitative assay of an
antibiotic or a
chemotherapeutic agent in a
body fluid (including
urine)(SP) ................. 23.00 23.00 23.00 23.00 23.00 23.00
1744 Quantitative assay of an
antibiotic or a
chemotherapeutic agent in a
body fluid (including
urine)(OP) ................. 17.25 17.25 17.25 17.25 17.25 17.25
1747 Serological tests for
hepatitis-for each test
(maximum of 2 tests)(SP) ... 23.00 23.00 23.00 23.00 23.00 23.00
1748 Serological tests for
hepatitis-for each test
(maximum of 2 tests)(OP) ... 17.25 17.25 17.25 17.25 17.25 17.25
1756 Agglutination tests
(screening)-one test (SP) .. 5.70 5.70 5.70 5.70 5.70
5.70
1757 Agglutination tests
(screening)-one test (OP) .. 4.30 4.30 4.30 4.30 4.30
4.30
1758 Agglutination tests
(screening) -two or more tests
(SP) ....................... 6.90 6.90 6.90 6.90 6.90
6.90
1759 Agglutination tests
(screening) -two or more tests
(OP) ....................... 5.20 5.20 5.20 5.20 5.20
5.20
1760 Agglutination test
(quantitative) , including
those for enteric fever and
brucellosis-one antigen
(SP) ....................... 17.20 17.20 17.20 17.20 17.20
17.20
1761 Agglutination test
(quantitative) , including
those for enteric fever and
brucellosis-one antigen
(OP) ....................... 12.90 12.90 12.90 12.90 12.90
12.90
1763 Agglutination tests
(quantitative) , including
those for enteric fever and
brucellosis-second to sixth
antigen-each antigen (SP) .. 9.20 9.20 9.20 9.20 9.20
9.20
1764 Agglutination tests
(quantitative) , including
those for enteric fever and
brucellosis-second to sixth
antigen-each antigen (OP) .. 6.90 6.90 6.90 6.90 6.90
6.90
1766 Agglutination tests
(quantitative) , including
those for enteric fever and
brucellosis-each antigen in
excess of six (SP) ......... 4.60 4.60 4.60 4.60 4.60
4.60
1767 Agglutination tests
(quantitative) , including
those for enteric fever and
brucellosis-each antigen in
excess of six (OP) ......... 3.45 3.45 3.45 3.45 3.45
3.45
1772 Flocculation test, including
V.D.R.L., Kahn, Kline or
similar test-one test (SP) . 5.70 5.70 5.70 5.70 5.70
5.70
1773 Flocculation test, including
V.D.R.L., Kahn, Kline or
similar test-one test (OP) . 4.30 4.30 4.30 4.30 4.30
4.30
1775 Flocculation test, including
V.D.R.L., Kahn, Kline or
similar tests-two or more
tests (SP) ................. 6.90 6.90 6.90 6.90 6.90
6.90
1776 Flocculation test, including
V.D.R.L., Kahn, Kline or
similar tests-two or more
tests (OP) ................. 5.20 5.20 5.20 5.20 5.20
5.20
1781 Complement fixation tests-one
test (SP) 23.00 23.00 23.00 23.00 23.00
23.00
1782 Complement fixation tests-one
test (OP) 17.25 17.25 17.25 17.25 17.25
17.25
1784 Complement fixation
tests-each test in excess of
one (SP) .................. 5.70 5.70 5.70 5.70 5.70
5.70
1785 Complement fixation
tests-each test in excess of
one (OP) .................. 4.30 4.30 4.30 4.30 4.30
4.30
1793 Fluorescent serum antibody
test (FTA test, FTA-absorbed
test or similar)-one test
(SP) ...................... 17.20 17.20 17.20 17.20 17.20
17.20
1794 Fluorescent serum antibody
test (FTA test, FTA-absorbed
test or similar)-one test
(OP) ...................... 12.90 12.90 12.90 12.90 12.90
12.90
1796 Each test referred to in Item
1793 in excess of one (SP) 9.20 9.20 9.20 9.20 9.20
9.20
1797 Each test referred to in Item
1794 in excess of one (OP) 6.90 6.90 6.90 6.90 6.90
6.90
1805 Haemagglutination tests-one
test (SP) ................. 11.40 11.40 11.40 11.40 11.40 11.40
1806 Haemagglutination tests-one
test (OP) 8.55 8.55 8.55 8.55 8.55
8.55
1808 Haemagglutination tests-each
test in excess of one (SP) 5.70 5.70 5.70 5.70 5.70
5.70
1809 Haemagglutination tests-each
test in excess of one (OP) 4.30 4.30 4.30 4.30 4.30
4.30
1823 Haemagglutination inhibition
tests-one test (SP) ....... 11.40 11.40 11.40 11.40 11.40 11.40
1824 Haemagglutination inhibition
tests-one test (OP) ....... 8.55 8.55 8.55 8.55 8.55
8.55
1826 Haemagglutination inhibition
tests-each test in excess of
one (SP) .................. 5.70 5.70 5.70 5.70 5.70
5.70
1827 Haemagglutination inhibition
tests-each test in excess of
one (OP) .................. 4.30 4.30 4.30 4.30 4.30
4.30
1839 Antistreptolysin O titre or
similar test, qualitative,
not associated with Item 1843
or 1846 (SP) .............. 5.70 5.70 5.70 5.70 5.70
5.70
1840 Antistreptolysin O titre or
similar test, qualitative,
not associated with Item 1844
or 1847 (OP) .............. 4.30 4.30 4.30 4.30 4.30
4.30
1843 Antistreptolysin O titre
test, antidesoxyribonuclease
B titre test or similar test
(quantitative) -one test (SP)
........................... 17.20 17.20 17.20 17.20 17.20 17.20
1844 Antistreptolysin O titre
test, antidesoxyribonuclease
B titre test or similar test
(quantitative) -one test (OP)
........................... 12.90 12.90 12.90 12.90 12.90 12.90
1846 Antistreptolysin O titre
test, antidesoxyribonuclease
B titre test or similar test
(quantitative) -two or more
tests (SP) 26.00 26.00 26.00 26.00 26.00
26.00
1847 Antistreptolysin O titre
test, antidesoxyribonuclease
B titre test or similar test
(quantitative) -two or more
tests (OP) 19.50 19.50 19.50 19.50 19.50
19.50
1851 Total and differential cell
count on any body fluid (SP)
........................... 11.40 11.40 11.40 11.40 11.40 11.40
1852 Total and differential cell
count on any body fluid (OP)
........................... 8.55 8.55 8.55 8.55 8.55
8.55
1858 Autogenous vaccine,
preparation of-each organism
(SP) ...................... 46.00 46.00 46.00 46.00 46.00
46.00
1859 Autogenous vaccine,
preparation of-each organism
(OP) ...................... 34.50 34.50 34.50 34.50 34.50
34.50
Division 4-Immunology
1877 Immunoelectrophoresis using
polyvalent antisera (SP) .. 34.50 34.50 34.50 34.50 34.50 34.50
1878 Immunoelectrophoresis using
polyvalent antisera (OP) .. 25.90 25.90 25.90 25.90 25.90 25.90
1884 Immunoelectrophoresis using
monovalent antiserum-each
antiserum (SP) ............ 5.70 5.70 5.70 5.70 5.70
5.70
1885 Immunoelectrophoresis using
monovalent antiserum-each
antiserum (OP) ............ 4.30 4.30 4.30 4.30 4.30
4.30
1888 Immunoglobulins G, A, M or D,
quantitative estimation of by
immunodiffusion or any other
method-estimation of one
immunoglobulin (SP) ....... 23.00 23.00 23.00 23.00 23.00 23.00
1889 Immunoglobulins G, A, M or D,
quantitative estimation of by
immunodiffusion or any other
method-estimation of one
immunoglobulin (OP) ....... 17.25 17.25 17.25 17.25 17.25 17.25
1891 Immunoglobulins G, A, M or D,
quantitative estimation of by
immunodiffusion or any other
method-estimation of each
immunoglobulin in excess of
one (SP) .................. 11.40 11.40 11.40 11.40 11.40 11.40
1892 Immunoglobulins G, A, M or D,
quantitative estimation of by
immunodiffusion or any other
method-estimation of each
immunoglobulin in excess of
one (OP) .................. 8.55 8.55 8.55 8.55 8.55
8.55
1897 Immunoglobulin E,
quantitative estimation of
(SP) ...................... 34.50 34.50 34.50 34.50 34.50
34.50
1898 Immunoglobulin E,
quantitative estimation of
(OP) ...................... 25.90 25.90 25.90 25.90 25.90
25.90
1903 Radioallergosorbent tests for
allergen
identification-identification
of one allergen (SP) ...... 11.40 11.40 11.40 11.40 11.40 11.40
1904 Radioallergosorbent tests for
allergen
identification-identification
of one allergen (OP) ...... 8.55 8.55 8.55 8.55 8.55
8.55
1905 Radioallergosorbent tests for
allergen
identification-identification
of each allergen referred to
in Item 1903 in excess of one
allergen to a maximum of
three allergens (SP) ...... 5.70 5.70 5.70 5.70 5.70
5.70
1906 Radioallergosorbent tests for
allergen
identification-identification
of each allergen referred to
in Item 1904 in excess of one
allergen to a maximum of
three allergens (OP) ...... 4.30 4.30 4.30 4.30 4.30
4.30
1911 Immunofluorescent detection
of tissue antibodies,
qualitative (not associated
with the service specified in
Item 1918), detection of one
antibody (SP) ............. 23.00 23.00 23.00 23.00 23.00 23.00
1912 Immunofluorescent detection
of tissue antibodies,
qualitative (not associated
with the service specified in
Item 1919), detection of one
antibody (OP) ............. 17.25 17.25 17.25 17.25 17.25 17.25
1913 Immunofluorescent detection
of tissue antibodies,
qualitative (not associated
with the service specified in
Item 1918), detection of each
antibody in excess of one
(SP) ...................... 11.40 11.40 11.40 11.40 11.40
11.40
1914 Immunofluorescent detection
of tissue antibodies,
qualitative (not associated
with the service specified in
Item 1919), detection of each
antibody in excess of one
(OP) ...................... 8.55 8.55 8.55 8.55 8.55
8.55
1918 Immunufluorescent detection
of tissue antibodies,
qualitative and
quantitative-detection and
estimation of each antibody
(SP) ...................... 28.50 28.50 28.50 28.50 28.50
28.50
1919 Immunofluorescent detection
of tissue antibodies,
qualitative and
quantitative-detection and
estimation of each antibody
(OP) ...................... 21.40 21.40 21.40 21.40 21.40
21.40
1924 Complement fixation tests on
human tissue antibodies-one
antibody (SP) ............. 23.00 23.00 23.00 23.00 23.00 23.00
1925 Complement fixation tests on
human tissue antibodies-one
antibody (OP) ............. 17.25 17.25 17.25 17.25 17.25 17.25
1926 Complement fixation tests on
human tissue antibodies-each
antibody in excess of one
(SP) ...................... 11.40 11.40 11.40 11.40 11.40
11.40
1927 Complement fixation tests on
human tissue antibodies-each
antibody in excess of one
(OP) ...................... 8.55 8.55 8.55 8.55 8.55
8.55
1935 Latex flocculation
test-qualitative,
quantitative or qualitative
and quantitative (SP) ..... 11.40 11.40 11.40 11.40 11.40 11.40
1936 Latex flocculation
test-qualitative,
quantitative or qualitative
and quantitave (OP) ....... 8.55 8.55 8.55 8.55 8.55
8.55
1941 Rose Waaler test,
quantitative, using sheep
cells (SP) ................ 23.00 23.00 23.00 23.00 23.00 23.00
1942 Rose Waaler test,
quantitative, using sheep
cells (OP) ................ 17.25 17.25 17.25 17.25 17.25 17.25
1943 Modified Rose Waaler test
using stabilised sheep cells,
not associated with Item 1941
(SP) ...................... 11.40 11.40 11.40 11.40 11.40
11.40
1944 Modified Rose Waaler test
using stabilised sheep cells,
not associated with Item 1942
(OP) ...................... 8.55 8.55 8.55 8.55 8.55
8.55
1948 Lupus erythematosus cells,
preparation and examination
of film for (SP) .......... 17.20 17.20 17.20 17.20 17.20 17.20
1949 Lupus erythematosus cells,
preparation and examination
of film for (OP) .......... 12.90 12.90 12.90 12.90 12.90 12.90
1955 Tanned erythrocyte
haemagglutination test for
tissue antibodies-one
antibody (SP) ............. 23.00 23.00 23.00 23.00 23.00 23.00
1956 Tanned erythrocyte
haemagglutination test for
tissue antibodies-one
antibody (OP) ............. 17.25 17.25 17.25 17.25 17.25 17.25
1957 Tanned erythrocyte
haemagglutination test for
tissue antibodies-each
antibody in excess of one
(SP) ...................... 11.40 11.40 11.40 11.40 11.40
11.40
1958 Tanned erythrocyte
haemagglutination test for
tissue antibodies-each
antibody in excess of one
(OP) ...................... 8.55 8.55 8.55 8.55 8.55
8.55
1965 Leucocyte fractionation as
preliminary test to specific
tests of leucocyte
function-by density gradient
centrifugation or any other
method (SP) ............... 34.50 34.50 34.50 34.50 34.50 34.50
1966 Leucocyte fractionation as
preliminary test to specific
tests of leucocyte
function-by density gradient
centrifugation or any other
method (OP) ............... 25.90 25.90 25.90 25.90 25.90 25.90
1971 Neutrophil or monocyte tests
for phagocytic
activity-visual techniques
(SP) ...................... 34.50 34.50 34.50 34.50 34.50
34.50
1972 Neutrophil or monocyte tests
for phagocytic
activity-visual techniques
(OP) 25.90 25.90 25.90 25.90 25.90
25.90
1973 Neutrophil or monocyte
function tests for phagocytic
activity-radioactive
techniques (SP) ........... 57.00 57.00 57.00 57.00 57.00 57.00
1974 Neutrophil or monocyte
function tests for phagocytic
activity-radioactive
techniques (OP) ........... 42.75 42.75 42.75 42.75 42.75 42.75
1981 Lymphocyte cell count-E.
rosette technique or similar
(SP) ...................... 46.00 46.00 46.00 46.00 46.00
46.00
1982 Lymphocyte cell count-E.
rosette technique or similar
(OP) ...................... 34.50 34.50 34.50 34.50 34.50
34.50
1987 B lymphocyte cell count-by
immunofluorescence or
immunoperoxidase (SP) ..... 46.00 46.00 46.00 46.00 46.00 46.00
1988 B lymphocyte cell count-by
immunofluorescence or
immunoperoxidase (OP) 34.50 34.50 34.50 34.50 34.50
34.50
1995 Lymphocyte function
test-visual transformation
(SP) ...................... 46.00 46.00 46.00 46.00 46.00
46.00
1996 Lymphocyte function
test-visual transformation
(OP) ...................... 34.50 34.50 34.50 34.50 34.50
34.50
1997 Lymphocyte function
test-radioactive techniques
(SP) ...................... 69.00 69.00 69.00 69.00 69.00
69.00
1998 Lymphocyte function
test-radioactive techniques
(OP) ...................... 51.75 51.75 51.75 51.75 51.75
51.75
2006 Tissue group typing (HLA
phenotyping) (SP) ......... 57.00 57.00 57.00 57.00 57.00 57.00
2007 Tissue group typing (HLA
phenotyping) (OP) ......... 42.75 42.75 42.75 42.75 42.75 42.75
2013 Mantoux, Schick, casoni or
similar test, not being a
test covered by Item 987 or
989 (SP) ................... 11.40 11.40 11.40 11.40 11.40 11.40
2014 Mantoux, Schick, casoni or
similar test, not being a
test covered by Item 987 or
989 (OP) ................... 8.55 8.55 8.55 8.55 8.55
8.55
2022 Skin sensitivity-induction
and detection of sensitivity
to chemical antigens (SP) 23.00 23.00 23.00 23.00 23.00
23.00
2023 Skin sensitivity-induction
and detection of sensitivity
to chemical antigens (OP) 17.25 17.25 17.25 17.25 17.25
17.25
Division 5-Histopathology
2041 Histopathology examination of
biopsy material-processing of
one or more paraffin blocks,
with all appropriate stains
and provision of professional
opinion (SP) ............... 80.00 80.00 80.00 80.00 80.00 80.00
2042 Histopathology examination of
biopsy material-processing of
one or more paraffin blocks,
with all appropriate stains
and provision of professional
opinion (OP) ............... 60.00 60.00 60.00 60.00 60.00 60.00
2048 Immediate frozen section
diagnosis of biopsy material
performed at the
pathologist's laboratory and
confirmatory histopathology
examination of this material
after the frozen section
using all appropriate stains
(SP) ....................... 104.00 104.00 104.00 104.00
104.00 104.00
2049 Immediate frozen section
diagnosis of biopsy material
performed at the
pathologist's laboratory and
confirmatory histopathology
examination of this material
after the frozen section
using all appropriate stains
(OP) ....................... 78.00 78.00 78.00 78.00 78.00
78.00
2056 Immediate frozen section
diagnosis of biopsy material
performed at a distance of
one or more kilometres from
the pathologist's laboratory
and confirmatory
histopathology examination of
this material after the
frozen section using all
appropriate stains (SP) .... 148.00 148.00 148.00 148.00 148.00 148.00
2057 Immediate frozen section
diagnosis of biopsy material
performed at a distance of
one or more kilometres from
the pathologist's laboratory
and confirmatory
histopathology examination of
this material after the
frozen section using all
appropriate stains (OP) .... 111.00 111.00 111.00 111.00 111.00 111.00
2060 Immunofluorescent or
immunoperoxidase
investigation of biopsy
specimen, including any other
histopathology examination of
the biopsy specimen and any
histopathology examination of
tissue obtained from the
patient at the time the
tissue subject to
immunofluorescent or
immunoperoxidase
investigation was
obtained-one or both
investigations (SP) ........ 104.00 104.00 104.00 104.00 104.00 104.00
2061 Immunofluorescent or
immunoperoxidase
investigation of biopsy
specimen, including any other
histopathology examination of
the biopsy specimen and any
histopathology examination of
tissue obtained from the
patient at the time the
tissue subject to
immunofluorescent or
immunoperoxidase
investigation was
obtained-one or both
investigations (OP) ........ 78.00 78.00 78.00 78.00 78.00 78.00
2062 Electron microscopy
examination of biopsy
specimen, including any other
histopathology examination of
the biopsy specimen and any
histopathology examination of
tissue obtained from the
patient at the time the
tissue subject to the
electron microscopy
examination was obtained
(SP) ....................... 120.00 120.00 120.00 120.00
120.00 120.00
2063 Electron microscopy
examination of biopsy
specimen, including any other
histopathology examination of
the biopsy specimen and any
histopathology examination of
tissue obtained from the
patient at the time the
tissue subject to the
electron microscopy
examination was obtained
(OP) ....................... 90.00 90.00 90.00 90.00 90.00
90.00
Division 6-Cytology
2081 Cytological examination for
pathological change of smears
from cervix and vagina, skin
or mucous membrane, excluding
nasal smears for cell count
covered by Item 1545, 1546,
1548 or 1549-each examination
(SP) ....................... 17.20 17.20 17.20 17.20 17.20
17.20
2082 Cytological examination for
pathological change of smears
from cervix and vagina, skin
or mucous membrane, excluding
nasal smears for cell count
covered by Item 1545, 1546,
1548 or 1549-each examination
(OP) ....................... 12.90 12.90 12.90 12.90 12.90
12.90
2091 Cytological examination of
body fluid or washings for
malignant cells-examination
of sputum, urine, bronchial
secretion, cerebrospinal
fluid, peritoneal fluid, any
similar fluid, gastric
washings, duodenal washings,
oesophageal washings or
colonic washings, including
collection of specimen-each
examination (SP) ........... 34.50 34.50 34.50 34.50 34.50 34.50
2092 Cytological examination of
body fluid or washings for
malignant cells-examination
of sputum, urine, bronchial
secretion, cerebrospinal
fluid, peritoneal fluid, any
similar fluid, gastric
washings, duodenal washings,
oesophageal washings or
colonic washings, including
collection of specimen-each
examination (OP) ........... 25.90 25.90 25.90 25.90 25.90 25.90
2093 Cytological examination for
malignant cells of material
obtained by fine needle
aspiration of solid tissues
(SP) ...................... 46.00 46.00 46.00 46.00 46.00
46.00
2094 Cytological examination for
malignant cells of material
obtained by fine needle
aspiration of solid tissues
(OP) ...................... 34.50 34.50 34.50 34.50 34.50
34.50
2104 Hormonal assessment by
cytological examination of
vaginal epithelium involving
cell count, index or both
(SP) 17.20 17.20 17.20 17.20 17.20
17.20
2105 Hormonal assessment by
cytological examination of
vaginal epithelium involving
cell count, index or both
(OP) 12.90 12.90 12.90 12.90 12.90
12.90
2111 Cytological examination for
pathological change of smears
from cervix and vagina with
hormonal assessment by
cytological examination of
vaginal epithelium involving
cell count, index or both
(SP) ...................... 28.50 28.50 28.50 28.50 28.50
28.50
2112 Cytological examination for
pathological change of smears
from cervix and vagina with
hormonal assessment by
cytological examination of
vaginal epithelium involving
cell count, index or both
(OP) ...................... 21.40 21.40 21.40 21.40 21.40
21.40
2148 Chromosome studies, including
preparation, count and
karyotyping of amniotic fluid
(SP) ...................... 172.00 172.00 172.00 172.00 172.00
172.00
2149 Chromosome studies, including
preparation, count and
karyotyping of amniotic fluid
(OP) ...................... 129.00 129.00 129.00 129.00 129.00
129.00
2155 Chromosome studies, including
preparation, count and
karyotyping of bone marrow
(SP) ...................... 114.00 114.00 114.00 114.00 114.00
114.00
2156 Chromosome studies, including
preparation, count and
karyotyping of bone marrow
(OP) ...................... 85.50 85.50 85.50 85.50 85.50
85.50
2161 Chromosome studies, including
preparation, count and
karyotyping of blood, skin or
any tissue or fluid not
referred to in Item 2148 or
2155-each study (SP) ...... 138.00 138.00 138.00 138.00 138.00 138.00
2162 Chromosome studies, including
preparation, count and
karyotyping of blood, skin or
any tissue or fluid not
referred to in Item 2149 or
2156-each study (OP) ...... 103.50 103.50 103.50 103.50 103.50 103.50
2170 Chromosome identification by
banding techniques (using
fluorescein, Giemsa or
centromeres staining)-one
method (SP) ............... 114.00 114.00 114.00 114.00 114.00 114.00
2171 Chromosome identification by
banding techniques (using
fluorescein, Giemsa or
centromeres staining)-one
method (OP) ............... 85.50 85.50 85.50 85.50 85.50 85.50
2173 Chromosome identification by
banding techniques (using
fluorescein, Giemsa or
centromeres staining)-two or
more methods (SP) ......... 172.00 172.00 172.00 172.00 172.00 172.00
2174 Chromosome identification by
banding techniques (using
fluorescein, Giemsa or
centromeres staining)-two or
more methods (OP) ......... 129.00 129.00 129.00 129.00 129.00 129.00
Division 8-Infertility and Pregnancy Tests
2201 Examination of semen for
presence of spermatozoa (SP)
........................... 6.90 6.90 6.90 6.90 6.90
6.90
2202 Examination of semen for
presence of spermatozoa (OP)
........................... 5.20 5.20 5.20 5.20 5.20
5.20
2211 Huhner's test (post-coital
test)-collection of sample
and examination of wet
preparation (SP) .......... 23.00 23.00 23.00 23.00 23.00 23.00
2212 Huhner's test (post-coital
test)-collection of sample
and examination of wet
preparation (OP) .......... 17.25 17.25 17.25 17.25 17.25 17.25
2215 Examination of semen
involving measurement of
volume, sperm count, gram or
similar stain, morphology by
differential count and
motility (including duration)
or viability or both (SP) . 34.50 34.50 34.50 34.50 34.50 34.50
2216 Examination of semen
involving measurement of
volume, sperm count, gram or
similar stain, morphology by
differential count and
motility (including duration)
or viability or both (OP) . 25.90 25.90 25.90 25.90 25.90 25.90
2225 Chemical analysis of
semen-analysis of one
substance (SP) ............ 17.20 17.20 17.20 17.20 17.20 17.20
2226 Chemical analysis of
semen-analysis of one
substance (OP) ............ 12.90 12.90 12.90 12.90 12.90 12.90
2227 Chemical analysis of
semen-analysis of two or more
substances (SP) ........... 28.50 28.50 28.50 28.50 28.50 28.50
2228 Chemical analysis of
semen-analysis of two or more
substances (OP) ........... 21.40 21.40 21.40 21.40 21.40 21.40
2247 Spermagglutinating and
immobilising antibodies, test
for-one test (SP) ......... 17.20 17.20 17.20 17.20 17.20 17.20
2248 Spermagglutinating and
immobilising antibodies, test
for-one test (OP) ......... 12.90 12.90 12.90 12.90 12.90 12.90
2249 Two or more tests referred to
in Item 2247 (SP) ......... 23.00 23.00 23.00 23.00 23.00 23.00
2250 Two or more tests referred to
in Item 2248 (OP) ......... 17.25 17.25 17.25 17.25 17.25 17.25
2264 Sperm penetrability, one or
more tests for-not associated
with Item 2211 (SP) ....... 23.00 23.00 23.00 23.00 23.00 23.00
2265 Sperm penetrability, one or
more tests for-not associated
with Item 2212 (OP) ....... 17.25 17.25 17.25 17.25 17.25 17.25
2272 Chorionic gonadotrophin
(beta-HCG), qualitative
estimation or quantitative
estimation or qualitative and
quantitative estimation by
one or more methods for any
purpose not covered by Item
2285 or 2286 (SP) .......... 11.40 11.40 11.40 11.40 11.40 11.40
2273 Chorionic gonadotrophin
(beta-HCG), qualitative
estimation or quantitative
estimation or qualitative and
quantitative estimation by
one or more methods for any
purpose not covered by Item
2285 or 2286 (OP) .......... 8.55 8.55 8.55 8.55 8.55
8.55
2285 Chorionic gonadotrophin
quantitative estimation of
(including serial dilutions)
for assessments of hormone
levels in the case of proven
hormone producing neoplasms
by one or more methods (SP) 34.50 34.50 34.50 34.50 34.50
34.50
2286 Chorionic gonadotrophin
quantitative estimation of
(including serial dilutions)
for assessments of hormone
levels in the case of proven
hormone producing neoplasms
by one or more methods (OP) 25.90 25.90 25.90 25.90 25.90
25.90
2287 Pregnancy pathology
assessment-comprising
haemoglobin estimation,
calculation of red cell
indices, blood film
examination, blood grouping,
examination for blood group
antibodies, test for
syphilis, test for rubella
antibodies, microscopic
examination of urine and
culture-one assessment in any
one pregnancy (SP) ......... 72.00 72.00 72.00 72.00 72.00 72.00
2288 Pregnancy pathology
assessment-comprising
haemoglobin estimation,
calculation of red cell
indices, blood film
examination, blood grouping,
examination for blood group
antibodies, test for
syphilis, test for rubella
antibodies, microscopic
examination of urine and
culture-one assessment in any
one pregnancy (OP) ......... 54.00 54.00 54.00 54.00 54.00 54.00
Division 8A-Examination not otherwise covered
2294 Pathology examination of any
body fluid or tissue not
covered by any other item in
this Part (SP) ............. 4.60 4.60 4.60 4.60 4.60
4.60
2295 Pathology examination of any
body fluid or tissue not
covered by any other item in
this Part (OP) ............. 3.45 3.45 3.45 3.45 3.45
3.45
Division 9-Simple Basic Pathology Tests
2334 Blood count consisting of
leucocyte count, erythrocyte
sedimentation rate,
examination of blood film
(including differential
leucocyte count) or any or
all of haemoglobin
estimation, haematocrit
estimation or erythrocyte
count-one procedure ........ 3.45 3.45 3.45 3.45 3.45
3.45
2335 Blood count consisting of
leucocyte count, erythrocyte
sedimentation rate,
examination of blood film
(including differential
leucocyte count) or any or
all of haemoglobin
estimation, haematocrit
estimation or erythrocyte
count-two procedures ....... 5.20 5.20 5.20 5.20 5.20
5.20
2336 Blood count consisting of
leucocyte count, erythrocyte
sedimentation rate,
examination of blood film
(including differential
leucocyte count) or any or
all of haemoglobin
estimation, haematocrit
estimation or erythrocyte
count-three or more
procedures ................ 6.90 6.90 6.90 6.90 6.90
6.90
2342 Microscopical examination of
urine ...................... 3.45 3.45 3.45 3.45 3.45
3.45
2346 Pregnancy test by one or more
immunochemical methods ..... 8.55 8.55 8.55 8.55 8.55
8.55
2352 Microscopical examination of
wet film other than urine .. 5.20 5.20 5.20 5.20 5.20
5.20
2357 Microscopical examination of
gram stained film .......... 6.90 6.90 6.90 6.90 6.90
6.90
2362 Chemical tests for occult
blood in faeces by reagent
stick, strip, tablet or
similar method ............. 1.75 1.75 1.75 1.75 1.75
1.75
2369 Microscopical examination
screening for fungi in skin,
hair or nails-one or more
sites ...................... 5.20 5.20 5.20 5.20 5.20
5.20
2374 Mantoux test ............... 8.55 8.55 8.55 8.55 8.55
8.55
2382 Casoni test for hydatid
disease .................... 8.55 8.55 8.55 8.55 8.55
8.55
2388 Schick test ................ 8.55 8.55 8.55 8.55 8.55
8.55
2392 Seminal examination for
presence of sper-matozoa ... 5.20 5.20 5.20 5.20 5.20
5.20
------------------------------------------------------------------------------
--
AustLII: Copyright Policy
| Disclaimers
| Privacy Policy
| Feedback